Vascular involvement in systemic sclerosis (scleroderma)

Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of Veterans Affairs Medical Center, Memphis, TN, USAA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pattanaik D, Brown M, Postlethwaite AE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/7f2ad46947d94c52a6cd3a2d21f4600c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f2ad46947d94c52a6cd3a2d21f4600c
record_format dspace
spelling oai:doaj.org-article:7f2ad46947d94c52a6cd3a2d21f4600c2021-12-02T00:13:23ZVascular involvement in systemic sclerosis (scleroderma)1178-7031https://doaj.org/article/7f2ad46947d94c52a6cd3a2d21f4600c2011-07-01T00:00:00Zhttp://www.dovepress.com/vascular-involvement-in-systemic-sclerosis-scleroderma-a7947https://doaj.org/toc/1178-7031Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of Veterans Affairs Medical Center, Memphis, TN, USAAbstract: Systemic sclerosis (SSc) is an acquired multiorgan connective tissue disease with variable mortality and morbidity dictated by clinical subset type. The etiology of the basic disease and pathogenesis of the systemic autoimmunity, fibrosis, and fibroproliferative vasculopathy are unknown and debated. In this review, the spectrum of vascular abnormalities and the options currently available to treat the vascular manifestations of SSc are discussed. Also discussed is how the hallmark pathologies (ie, how autoimmunity, vasculopathy, and fibrosis of the disease) might be effected and interconnected with modulatory input from lysophospholipids, sphingosine 1-phosphate, and lysophosphatidic acid.Keywords: fibrosis, autoimmunity, vasculopathy, S1P, LPAPattanaik DBrown MPostlethwaite AEDove Medical PressarticlePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol 2011, Iss default, Pp 105-125 (2011)
institution DOAJ
collection DOAJ
language EN
topic Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Pattanaik D
Brown M
Postlethwaite AE
Vascular involvement in systemic sclerosis (scleroderma)
description Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of Veterans Affairs Medical Center, Memphis, TN, USAAbstract: Systemic sclerosis (SSc) is an acquired multiorgan connective tissue disease with variable mortality and morbidity dictated by clinical subset type. The etiology of the basic disease and pathogenesis of the systemic autoimmunity, fibrosis, and fibroproliferative vasculopathy are unknown and debated. In this review, the spectrum of vascular abnormalities and the options currently available to treat the vascular manifestations of SSc are discussed. Also discussed is how the hallmark pathologies (ie, how autoimmunity, vasculopathy, and fibrosis of the disease) might be effected and interconnected with modulatory input from lysophospholipids, sphingosine 1-phosphate, and lysophosphatidic acid.Keywords: fibrosis, autoimmunity, vasculopathy, S1P, LPA
format article
author Pattanaik D
Brown M
Postlethwaite AE
author_facet Pattanaik D
Brown M
Postlethwaite AE
author_sort Pattanaik D
title Vascular involvement in systemic sclerosis (scleroderma)
title_short Vascular involvement in systemic sclerosis (scleroderma)
title_full Vascular involvement in systemic sclerosis (scleroderma)
title_fullStr Vascular involvement in systemic sclerosis (scleroderma)
title_full_unstemmed Vascular involvement in systemic sclerosis (scleroderma)
title_sort vascular involvement in systemic sclerosis (scleroderma)
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/7f2ad46947d94c52a6cd3a2d21f4600c
work_keys_str_mv AT pattanaikd vascularinvolvementinsystemicsclerosisscleroderma
AT brownm vascularinvolvementinsystemicsclerosisscleroderma
AT postlethwaiteae vascularinvolvementinsystemicsclerosisscleroderma
_version_ 1718403873594408960